1-25563670-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_015627.3(LDLRAP1):c.626C>T(p.Thr209Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000787 in 1,613,706 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T209S) has been classified as Uncertain significance.
Frequency
Consequence
NM_015627.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LDLRAP1 | NM_015627.3 | c.626C>T | p.Thr209Ile | missense_variant | 7/9 | ENST00000374338.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LDLRAP1 | ENST00000374338.5 | c.626C>T | p.Thr209Ile | missense_variant | 7/9 | 1 | NM_015627.3 | P1 | |
LDLRAP1 | ENST00000484476.5 | n.348C>T | non_coding_transcript_exon_variant | 2/4 | 1 | ||||
LDLRAP1 | ENST00000474283.1 | n.37C>T | non_coding_transcript_exon_variant | 1/3 | 3 | ||||
LDLRAP1 | ENST00000488127.1 | n.1096C>T | non_coding_transcript_exon_variant | 6/7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000368 AC: 56AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 26AN: 250554Hom.: 0 AF XY: 0.0000590 AC XY: 8AN XY: 135562
GnomAD4 exome AF: 0.0000458 AC: 67AN: 1461378Hom.: 0 Cov.: 31 AF XY: 0.0000426 AC XY: 31AN XY: 726990
GnomAD4 genome AF: 0.000394 AC: 60AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.000362 AC XY: 27AN XY: 74494
ClinVar
Submissions by phenotype
Hypercholesterolemia, familial, 4 Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Sep 09, 2021 | This sequence change replaces threonine with isoleucine at codon 209 of the LDLRAP1 protein (p.Thr209Ile). The threonine residue is moderately conserved and there is a moderate physicochemical difference between threonine and isoleucine. This variant is present in population databases (rs141522360, ExAC 0.1%). This variant has not been reported in the literature in individuals affected with LDLRAP1-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Dec 07, 2021 | - - |
Familial hypercholesterolemia Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 16, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at